N85.02
Endometrial intraepithelial neoplasia [EIN]
Clinical Classification Guidelines
Inclusion Terms
- Endometrial hyperplasia with atypia
Excludes Type 1
- malignant neoplasm of endometrium (with endometrial intraepithelial neoplasia [EIN]) (C54.1)
Medical Intelligence & Overview
Endometrial intraepithelial neoplasia (EIN), classified under ICD-10 code N85.02, is a precancerous condition affecting the lining of the uterus. It is characterized by abnormal cell growth and changes in the endometrial tissue, which can sometimes progress to endometrial cancer if left untreated. Often associated with endometrial hyperplasia with atypia, EIN signals the need for careful medical evaluation and monitoring. Recognizing the signs, understanding the causes, and exploring possible treatment options can help manage this condition effectively.
Causes & Symptoms
Clinical Causes: Hormonal imbalance, especially excess estrogen without adequate progesterone Obesity, which increases estrogen levels Irregular menstrual cycles or anovulation Use of hormonal therapy, including estrogen-only treatments Certain genetic conditions or mutations affecting endometrial cell growth Ageing, with increased risk in perimenopausal and postmenopausal women
Key Symptoms: Abnormal uterine bleeding, such as heavy or irregular periods Spotting or bleeding between periods Unusual pelvic discomfort or pressure A feeling of fullness or heaviness in the pelvis Postmenopausal bleeding
Diagnostic & Treatment
Diagnosis Path: Diagnosis usually begins with a detailed medical history and pelvic examination. To confirm EIN, healthcare providers typically perform a biopsy of the uterine lining, often through procedures like hysteroscopy or dilatation and curettage (D&C). Microscopic examination of the tissue reveals abnormal cell growth with atypia. Additional tests may include ultrasound imaging of the uterus to assess the endometrial thickness and rule out other conditions. Accurate diagnosis is essential to determine the appropriate management plan.
Treatment Protocols: Treatment options depend on the severity of the condition, the patient's age, and reproductive plans. Common approaches include: - **Hormonal Therapy:** Progestin medications may be prescribed to counteract estrogen effects and induce regression of abnormal tissue. - **Surgical Intervention:** Procedures such as hysterectomy (removal of the uterus) might be recommended for women who do not wish to preserve fertility, or if there is a significant risk of progression to cancer. - **Monitoring:** Regular follow-up with ultrasounds and repeat biopsies to monitor for changes or regression of the abnormal tissue. - **Lifestyle Modifications:** Addressing risk factors like weight management and hormonal imbalances may help reduce risk. Early diagnosis and intervention are key to preventing progression to endometrial carcinoma.
Clinical Advice & FAQs
Billing Guidance
Is N85.02 a billable ICD-10 code?
Yes, N85.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N85.02?
Clinical documentation must specify the nature of Endometrial intraepithelial neoplasia [EIN] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference